Mingzhi Zhu
1 Jianshe East Road
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Retrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab.
Journal: Breast cancer (Dove Medical Press)
Published: February 21, 2024
Neoadjuvant pyrotinib plus trastuzumab and chemotherapy for HER2-positive breast cancer: a prospective cohort study.
Journal: World journal of surgical oncology
Published: August 14, 2023
Clinical observation of neoadjuvant chemotherapy with pyrotinib plus trastuzumab in HER2-positive breast cancer: a cohort study.
Journal: Gland surgery
Published: November 05, 2021
Circular RNA circ_IRAK3 contributes to tumor growth through upregulating KIF2A via adsorbing miR-603 in breast cancer.
Journal: Cancer cell international
Published: October 25, 2021
Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells.
Journal: Clinical breast cancer
Published: September 26, 2021
Transcription Factor FOSL1 Enhances Drug Resistance of Breast Cancer through DUSP7-Mediated Dephosphorylation of PEA15.
Journal: Molecular cancer research : MCR
Published: August 11, 2021
CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis.
Journal: Cancer cell international
Published: April 19, 2021
Aberrant super-enhancer-driven oncogene ENC1 promotes the radio-resistance of breast carcinoma.
Journal: Cell death & disease
Published: March 12, 2021
Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
Journal: Cell cycle (Georgetown, Tex.)
Published: October 30, 2020
Coexpression Module Construction by Weighted Gene Coexpression Network Analysis and Identify Potential Prognostic Markers of Breast Cancer.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: October 14, 2020
Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU).
Journal: Cell death & disease
Published: August 03, 2020
Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer.
Journal: Frontiers in genetics
Published: April 26, 2020
Last Updated: 09/26/2026